Clinical Trials Logo

Clinical Trial Summary

This will be a randomized investigator blinded study of 40 men age 20-60 (inclusive) with symptoms of mild-moderate PFB based on Investigator Global Assessment (IGA). Subjects will be divided into two groups: the Control group of 20 subjects and the Experimental group of 20 Subjects. Subjects will be seen at Screening/Baseline, and 6 weeks.

All subjects will use their normal razors and shave products during the six week study. The Experimental group of subjects will also be given the study product Pre-Shave Gel and Cleansing Brush.


Clinical Trial Description

This will be a randomized investigator blinded study of up to 40 men age 20-60 (inclusive) with symptoms of mild-moderate PFB based on Investigator Global Assessment (IGA). Subjects will be divided into two groups: the Control group of 20 subjects and the Experimental group of 20 Subjects. Subjects will be seen at Screening/Baseline, and 6 weeks.

All subjects will use their normal razors and shave products during the six week study. The Experimental group of subjects will also be given the study product Pre-Shave Gel and Cleansing Brush. The study gel and brush will be used prior to their normal shave routine.Quantitative lesion counts will be done by trained clinicians at each visit. Efficacy assessments include Investigator Global Assessment (IGA) scoring ;


Study Design


Related Conditions & MeSH terms


NCT number NCT03043534
Study type Interventional
Source Wake Forest University Health Sciences
Contact
Status Completed
Phase N/A
Start date November 12, 2015
Completion date October 12, 2016

See also
  Status Clinical Trial Phase
Terminated NCT04403282 - Topical Eflornithine for Pseudofolliculitis Barbae: Randomized Controlled Trial Phase 4
Active, not recruiting NCT03569956 - Shaving Satisfaction in Males With Skin Irritation From Shaving N/A
Completed NCT04993066 - Clinical Evaluation to Assess the Safety and Efficacy of GentleMax Pro Plus N/A
Completed NCT00176995 - Effect of 15% Eflornithine Hydrochloride Cream on African-American Males With Pseudofolliculitis Barbae Phase 2
Completed NCT00402129 - Low Fluence 1064nm Laser Hair Reduction for Pseudofolliculitis Barbae in Skin Types IV, V, VI N/A
Withdrawn NCT04220502 - Magic Shave Powder Gold's Affects on the Occurrence of Pseudofolliculitis Barbae Early Phase 1